Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Does free thyroxine (fT4) predict risk of atherosclerotic cardiovascular disease (ASCVD)?

Event: ESC Congress 2019

Topic: Epidemiology

Session: Risk Factors and Prevention, Cardiovascular Disease in Special Populations

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources